Notice: This company has been marked as potentially delisted and may not be actively trading. Gamida Cell (GMDA) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Gamida Cell Announces New Leadership Under Ownership of Highbridge Capital ManagementJune 18, 2024 | businesswire.comGamida Cell files for U.S. bankruptcy as it undergoes restructuringApril 23, 2024 | bizjournals.comQ4 2023 Gamida Cell Ltd Earnings CallMarch 28, 2024 | finance.yahoo.comGamida Cell, Ltd: Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital ManagementMarch 27, 2024 | finanznachrichten.deGamida Cell, Ltd: Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company UpdateMarch 27, 2024 | finanznachrichten.deWhy Gamida Cell Shares Are Falling TodayMarch 27, 2024 | msn.comGMDA Stock Earnings: Gamida Cell Beats EPS, Beats Revenue for Q4 2023March 27, 2024 | investorplace.comWhy Is Gamida Cell (GMDA) Stock Down 82% Today?March 27, 2024 | investorplace.comGamida Cell GAAP EPS of $0.57 beats by $0.72, revenue of $1.78M beats by $0.72MMarch 27, 2024 | msn.comGamida Cell Annual Net Loss Narrows; To Be Taken PrivateMarch 27, 2024 | markets.businessinsider.comGamida Cell starts restructuring process supported by Highbridge Capital, stock downMarch 27, 2024 | msn.comGamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company UpdateMarch 27, 2024 | globenewswire.comGamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital ManagementMarch 27, 2024 | globenewswire.comGamida Cell Earnings PreviewMarch 27, 2024 | benzinga.comGamida Cell to Report Fourth Quarter and Full-Year 2023 Financial ResultsMarch 22, 2024 | globenewswire.comGamida Cell (GMDA) Earnings Dates & ReportsMarch 4, 2024 | investing.comGamida Cell (GMDA) Price Target Increased by 8.33% to 4.42February 24, 2024 | msn.comGamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®February 23, 2024 | globenewswire.comGamida Cell Stock (NASDAQ:GMDA), Short Interest ReportFebruary 22, 2024 | benzinga.comGamida Cell Ltd. (GMDA)February 21, 2024 | finance.yahoo.comGamida Cell Ltd (GMDA)January 30, 2024 | investing.comGamida Cell just downgraded at JMP Securities, here's whyJanuary 29, 2024 | realmoney.thestreet.comGamida Cell, Ltd: Gamida Cell Actively Pursuing Strategic AlternativesJanuary 29, 2024 | finanznachrichten.deGamida Cell Pursues Strategic Options Including Asset Sale, MergerJanuary 29, 2024 | marketwatch.comGamida Cell Actively Pursuing Strategic Alternatives - Quick FactsJanuary 29, 2024 | markets.businessinsider.comGamida Cell Actively Pursuing Strategic AlternativesJanuary 29, 2024 | finance.yahoo.comGamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®January 17, 2024 | finance.yahoo.comGamida Cell Ltd GMDAJanuary 9, 2024 | morningstar.comGMDA Jan 2024 1.000 putDecember 24, 2023 | ca.finance.yahoo.comPiper Sandler Keeps Their Buy Rating on Gamida Cell (GMDA)December 6, 2023 | markets.businessinsider.comBuy Rating Affirmed for Gamida Cell Amid Omisirge’s Market PotentialDecember 5, 2023 | markets.businessinsider.comGamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023November 28, 2023 | finance.yahoo.comGamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare ConferenceNovember 20, 2023 | finance.yahoo.comVernon Bernardino Recommends ‘Buy’ for Gamida Cell: Promising Growth Trajectory and Expanding Market Access underpin the RatingNovember 16, 2023 | markets.businessinsider.comGamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call TranscriptNovember 15, 2023 | finance.yahoo.comQ3 2023 Gamida Cell Ltd Earnings CallNovember 15, 2023 | finance.yahoo.comBuy Rating Justified: Gamida Cell’s Progress and Strategic Moves Despite Capital ConstraintsNovember 15, 2023 | markets.businessinsider.comGamida Cell falls after Q3 revenue missNovember 14, 2023 | msn.comGamida Cell, Ltd: Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company UpdateNovember 14, 2023 | finanznachrichten.deRecap: Gamida Cell Q3 EarningsNovember 14, 2023 | benzinga.comGamida Cell Reports Third Quarter 2023 Financial Results and Provides Company UpdateNovember 14, 2023 | finance.yahoo.comGamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual MeetingNovember 4, 2023 | finance.yahoo.comGamida Cell to Report Third Quarter 2023 Financial ResultsNovember 1, 2023 | finance.yahoo.comGamida Cell's Blood Cancer Candidate Shows Encouraging Anti-Tumor Activity In Heavily Pretreated PatientsOctober 17, 2023 | msn.comAnalysts Offer Insights on Healthcare Companies: Gamida Cell (GMDA) and Ocular Therapeutix (OCUL)October 17, 2023 | markets.businessinsider.comGamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201October 16, 2023 | finance.yahoo.comGamida Cell Issues Update on Israel OperationsOctober 9, 2023 | finance.yahoo.comGamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the MesaOctober 2, 2023 | finance.yahoo.comPleasing Signs As A Number Of Insiders Buy Gamida Cell StockSeptember 29, 2023 | finance.yahoo.comJMP Securities Reiterates Gamida Cell (GMDA) Market Outperform RecommendationSeptember 28, 2023 | msn.com Get Gamida Cell News Delivered to You Automatically Sign up to receive the latest news and ratings for GMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto That’s Making Wall Street Sweat (Ad)The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest. Click here to discover our #1 crypto for the market right now – poised for massive growth GMDA Media Mentions By Week GMDA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GMDA News Sentiment▼0.000.56▲Average Medical News Sentiment GMDA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GMDA Articles This Week▼01▲GMDA Articles Average Week Get Gamida Cell News Delivered to You Automatically Sign up to receive the latest news and ratings for GMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Finch Therapeutics Group News Calidi Biotherapeutics News IN8bio News AIM ImmunoTech News Evaxion Biotech A/S News Turnstone Biologics News CERo Therapeutics News Senti Biosciences News NKGen Biotech News Coeptis Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GMDA) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gamida Cell Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gamida Cell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
